It has been reported that suppression of N-methyl-D-aspartate (NMDA) receptor function by ketamine may trigger apoptosis of neurons when given repeatedly during the brain growth spurt period. Because microPET scans can provide in vivo molecular imaging at sufficient resolution, it has been proposed as a minimally invasive method for detecting apoptosis using the tracer 18 F-labeled annexin V. In this study, the effect of ketamine on the metabolism and integrity of the rat brain were evaluated by investigating the uptake and retention of 18 F-fluorodeoxyglucose (FDG) and 18 F-annexin V using microPET imaging. On postnatal day (PND) 7, rat pups in the experimental group were exposed to six injections of ketamine (20 mg/kg at 2-h intervals) and control rat pups received six injections of saline. On PND 35, 37 MBq (1 mCi) of 18 F-FDG or 18 F-annexin V was injected into the tail vein of treated and control rats, and static microPET images were obtained over 1 (FDG) and 2 h (annexin V) following the injection. No significant difference was found in 18 F-FDG uptake in the regions of interest (ROIs) in the brains of ketamine-treated rats compared with saline-treated controls. The uptake of 18 F-annexin V, however, was significantly increased in the ROI of ketamine-treated rats. Additionally, the duration of annexin V tracer washout was prolonged in the ketamine-treated animals. These results demonstrate that microPET imaging is capable of distinguishing differences in retention of 18 F-annexin V in different brain regions and suggests that this approach may provide a minimally invasive biomarker of neuronal apoptosis in rats.
Ketamine, a dissociative anesthetic with a short duration of action, is primarily used for the induction and maintenance of general anesthesia, usually in combination with a sedative drug (Kohrs and Durieux, 1998) . It is widely used in pediatric surgery and has a wide range of effects in humans (Mellon et al., 2007) . Recent studies on anesthetics have demonstrated that administration of ketamine causes widespread apoptotic neurodegeneration in the neonatal rat brain (Ikonomidou et al., 1999; Olney et al., 2002; Scallet et al., 2004) .
It is well known that activation of N-methyl-D-aspartate (NMDA) receptors by glutamate plays an important role in brain development. Normal activation of NMDA receptors is critical for neuronal differentiation, establishment, and outgrowth. Continuous blockade of NMDA receptors, especially during critical period of central nervous system development, may reduce the establishment of redundant synapses in the developing brain (du Bois and Huang, 2007; Ikonomidou et al., 1999; Scallet et al., 2004; Slikker et al., 2005 Slikker et al., , 2007 Wang et al., 2007) . This critical period of rapid growth of neurons and synaptogenesis-the brain growth spurt-occurs in different species at different times relative to birth. In rats and mice, the brain growth spurt occurs during postnatal days (PNDs) 1-14, whereas in humans, it occurs from the sixth month of gestation to several years after birth (du Bois and Huang, 2007) . During this period, the brain is more susceptible to alterations in NMDA receptor function and apoptosis can be observed in the cortex and limbic system after the administration of NMDA antagonists (du Bois and Huang, 2007; Olney et al., 2002) .
As a noncompetitive antagonist of NMDA receptors, ketamine-induced suppression of neuronal activity during the brain growth spurt triggers apoptosis in neurons (Ikonomidou et al., 1999; Olney et al., 2002; Scallet et al., 2004; Slikker et al., 2007; Wang et al., 2007) . In our previous studies, multiple doses of ketamine (20 mg/kg 3 6) given to PND 7 infant rats triggers a massive wave of apoptotic neurodegeneration affecting many neurons in several major regions of the developing brain, especially the frontal cortex (Zou et al., 2009) . These results are consistent with previous reports that exposure of the developing brain to NMDA antagonists such as ketamine or phencyclidine results in widespread and dosedependent apoptotic neurodegeneration and suggest that the frontal cortex is the brain region most vulnerable to ketamine-induced neurotoxicity (Ikonomidou et al., 1999 (Ikonomidou et al., , 2001 Jevtovic-Todorovic et al., 2003; Olney et al., 2002) .
Positron emission tomography (PET) allows one to obtain noninvasive, in vivo measurements of multiple molecular processes in various organs. The development of microPET imaging applications has provided the ability to collect sensitive and quantitative three-dimensional molecular information from the living brains of small animals such as rats and mice (Chen et al., 2004 (Chen et al., , 2009 Hosoi et al., 2005; Kornblum et al., 2000; Moore et al., 2000; Ohashi et al., 2008) . Since it is important to obtain a sufficient data set from living animals to allow for repeated assessment of the neurotoxic effects associated with early exposure to ketamine, we have developed a microPET protocol to measure 18 F-fluorodeoxyglucose (FDG) and 18 F-annexin V uptake as quantitative markers of metabolic activity and neuronal apoptosis, respectively, in the living rat brain.
MATERIALS AND METHODS
Drugs. Ketamine hydrochloride (Ketaset; Fort Dodge Animal Health, Fort Dodge, IA) was diluted in saline. Ketamine was identified and its purity (>99%) confirmed with high performance liquid chromatography (HPLC) and mass spectrometry.
Animals. All animal procedures were approved by the National Center for Toxicological Research (NCTR) Institutional Animal Care and Use committee and conducted in full accordance with the public health service Policy on Humane Care and Use of Laboratory Animals. All animals were housed in the animal facility at NCTR (2 rats/cage) with room temperature maintained at 22°C ± 2°C. The animals were maintained on standard rat chow and water under a light/dark cycle of 12/12 h where the light cycle began at 7:00 A.M. and the dark cycle began at 7:00 P.M. Seven-day-old (PND 7) Sprague Dawley (male and female) rat pups (obtained from the NCTR breeding colony; average body weight 12-18 g) were used to examine the potential neurotoxic effects of ketamine. Rat pups were randomly assigned to control or ketamine-treated groups. Either ketamine hydrochloride or saline (10 ll/g) was injected sc using a 30-gauge needle. Between injections, pups were returned to their dam for warmth and to reduce potential stressors. Doses of ketamine (20 mg/kg/ injection) were administered in six injections at 2-h intervals (Zou et al., 2009) . Control animals received saline at the same time points.
After treatment, rat pups in both the control and experimental groups were returned to the animal facility until microPET scanning on PND 35. Each rat was weighed before scanning (125-135 g, average).
Radiotracer preparation and injection. F-N-hydroxysuccinimidyl fluorobenzoate was prepared by the method of Haka et al. (1989) in 40-60% chemical yield from fluoride ion. After HPLC purification, this was reacted with annexin V (100 lg; Anaspec Co., San Jose, CA) in 0.125 ml of pH 8.5 borate buffer (as described by Grierson) to give radiolabeled annexin V in 10-20% chemical yield from the succinimide. Annexin V was then purified from the unreacted labeled species and reaction salts by elution in normal saline for injection (The United States Pharmacopeia) through a 1 3 20-cm Sephadex G-15 column.
The overall chemical yield of the radiolabeling process from starting fluoride to radiolabeled annexin V was 3-10%. The corresponding radiochemical yield at the end of the 3-h synthetic process was 1-4%. This was sufficient to produce 40-3000 MBq (10-60 mCi) of 18 F-annexin V at the end of synthesis for use in these experiments.
The microPET. A commercial high-resolution small animal PET scanner, Focus 220 (Siemens Preclinical Solution, Knoxville, TN) was used to quantitatively acquire images of the rat brain. The scanner has 96 lutetium oxyorthosilicate detectors and provides a transaxial resolution of 1.35-mm fullwidth at half-maximum. Data were collected in a 128 3 128 3 95 matrix with a pixel width of 0.475 mm and a slice thickness of 0.815 mm.
The microPET image acquisition. microPET images of rats were acquired on PND 35. Rats were initially anesthetized with 1.5% isofluorane gas delivered through a custom face mask. For each imaging process, 18 F-FDG or 18 F-annexin V (37 MBq) was injected into the tail vein of anesthetized rats. Following the injection, a set of serial microPET images was collected to assess the influx of the tracer for 1 h (12 frames, 5 min each, for FDG) and 2 h (24 frames, 5 min each, for annexin V).
Western blot analysis. For the quantification of protein expression, Western blot analysis was used. After the microPET scans were complete on PND 35, the brains of animals anesthetized with 1.5% isofluorane gas were removed quickly. Brain tissue from the frontal cortical level was placed in lysis buffer (1% nonyl phenoxylpolyethoxylethanol, 0.5% sodium deoxycholate, 0.1% SDS in normal PBS; pH 6.8) containing 10 ll/ml protease inhibitor cocktail (Sigma-Aldrich) and homogenized. Protein was extracted immediately and the supernatants were stored at À70°C. The protein concentrations were measured using a BCA protein assay kit (Pierce, Rockford, IL). Equal amounts of protein (10 lg) from the supernatant fractions were loaded into each lane, run on SDSpolyacrylamide gels with a Tris-glycine running buffer system and then transferred to a polyvinylidene difluoride membrane (0.2 lm) in a Mini Electrotransfer Unit (Bio-Rad, Hercules, CA). The blots were probed with antiBax (1:2000, polyclonal; Santa Cruz Biotechnology Inc., Santa Cruz, CA) and anti-actin (1:3000, monoclonal; Chemicon, Temecula, CA). Immunoblot analysis was performed using horseradish peroxidase-conjugated anti-mouse and antirabbit IgG using enhanced chemiluminescence Western blotting detection reagents (Amersham Bioscience, Piscataway, NJ). The bands corresponding to Bax and b-actin were scanned and densitometrically analyzed using an automatic image analysis system (Alpha Innotech Corporation, San Leandro, CA). These quantitative analyses were normalized to b-actin (after stripping).
Data analysis. Medical image analysis software, ASIPro (Concorde Microsystems, Inc., Knoxville, TN), was used in the statistical analyses for the regions of interest (ROIs). ROIs were outlined and measured by ASIProprovided tools. Radioactivity of different brain areas was also quantified using this software. All images are displayed on the same color scale, shown in Figure 1 . Tracer accumulation in the ROI of the left frontal cortex was converted to standard uptake values (SUVs). The SUVs for ROIs at different time points were compared between control and ketamine groups using Student's t-test. All values are presented as mean ± SEM. A p value of less than 0.05 was considered significant.
RESULTS

The microPET Images of Rat Brain Using 18 F-FDG
Representative microPET images taken after administration of 18 F-FDG tracer are shown in Figure 1 . Dynamic FDG uptake in the cerebral cortex of control and treated brains is shown in a multiplane manner. Over a 1-h scanning process, 12 frames of images were constructed: each frame records and plots the total radioactivity of tissues over 5 min. Images in Figure 1 were collected from frame 9 (40-45 min after injection), and there were no significant differences for FDG uptake between control and ketamine-treated rats. 
Dynamic 18 F-FDG Uptake in the Cerebral Cortex
Dynamic images were obtained for 60 min following the 18 F-FDG injection. FDG was taken up by the brain and the tracer accumulation in the ROI in the frontal cortex (left) was investigated. Based on the images from both control and treated rats, the radioactivity recorded from the frontal cortex increased and peaked at~10 min, then gradually decreased over the approximately 60 min after the 18 F-FDG injection. SUVs were calculated and used in the analysis of the radioactivity in the ROI. Dynamic microPET images demonstrated that no significant differences in brain 18 F-FDG uptake and retention were detected between control and ketaminetreated rats (Fig. 2) .
The microPET Images of Rat Brain after 18 F-Annexin V Administration On PND 35, microPET scans on each rat were recorded for 2 h after injection of 18 F-annexin V. Figure 3 shows two sets of microPET images of the ROI from a control rat and a ketamine-treated rat. These eight frames of images from each rat illustrate the distribution of 18 F-annexin V at different time points (0-40 min following the tracer injection). In the control rat, the accumulation of the tracer peaked 5 min after the 18 F-annexin V injection and then decreased rapidly. However, in the ketamine-treated brain, accumulation of 18 Fannexin V also peaked at 5 min, but remained at relatively high levels for 40 min after the 18 F-annexin V injection.
Dynamic 18 F-Annexin V Uptake in the Cerebral Cortex
Dynamic images were obtained for 120 min following the injection of 18 F-annexin V. In Figure 4 , typical time activity curves for the ROI in the left frontal cortex from a control and a ketamine-treated rat are shown. In the control rat, 18 F-annexin V was transported into the ROI of the brain and quickly washed out. However, in the ketamine-treated rat, 18 F-annexin V accumulated quickly in the ROI but decreased at a slower rate. According to the curve, the washout is not as rapid as that seen in the control rat. Figure 5 demonstrates the dynamic uptake of the ketamine-treated rats is significantly higher at all time points (from 5 to 120 min following radiotracer injection) than in the controls. The 18 F-annexin V levels in the ketaminetreated rats were highest at 35 min and gradually decreased but still remained at relatively high levels 120 min after the 18 F-annexin V injection. In general, the washout of tracer in the ketamine-treated rats takes much longer compared to the controls.
Assessment of Ketamine-Induced Neurotoxicity
To further confirm the presence of neuronal apoptosis in the brains of PND 35 rats, Western blot analyses of Bax protein in the frontal cortex of ketamine-treated and control rats were performed. A single protein band at 21 kDa was recognized by the polyclonal rabbit anti-Bax antibody. According to Figure 6 , compared to control rats, quantitative densitometry revealed significantly increased Bax protein expression in the brain tissue of ketamine-treated rats.
DISCUSSION
As an advanced imaging technology, microPET is a modality applicable at the molecular level that can provide valuable insights into biochemical, physiological, pathological, and pharmacological processes in vivo (Chatziioammou 2002; Luker et al., 2003; Myers 2001; Phelps 2000) . In the present study, microPET technology was employed to investigate ketamine-induced toxic processes in the rat brain. In our previous study (Zou et al., 2009) , in order to investigate the dose response to ketamine treatment, rat pups (PND 7) were exposed to 5, 10, or 20 mg/kg ketamine in single or multiple injections with 2-h intervals between the multiple injections. Compared with controls, multiple ketamine injections (20 mg/ kg 3 6) produced the most severe neuronal damage. Therefore, in the current study, treatment with six injections of ketamine (20 mg/kg at 2-h intervals) was utilized for rats in the experimental group.
In order to obtain a dynamic assessment of the neurotoxic effects associated with early exposure to ketamine, we designed using microPET to study ketamine-treated rats at different developmental stages. In the current study, rats were scanned on PND 35 to determine if the effects of an earlier exposure (PND 7) to ketamine could still be detected.
The first part of this microPET protocol was designed to evaluate the effects of early ketamine exposure on the metabolic activity of the brain on PND 35.
18 F-FDG is the most widely used radiotracer for the assessment of glucose metabolism in the brain, and the uptake of 18 F-FDG by neurons can be used to evaluate neuronal metabolic activation (Chen et al., 2009; Ohashi et al., 2008; Paul et al., 2009) . Our microPET data provided clear images with sufficient resolution and the software accompanied with the scanner provided quantitative measurements of glucose metabolism. FDG accumulation reached a peak at about 20-30 min after FDG administration and remained at a plateau until at least 60 min after the injection. The uptake and accumulation of FDG in the ROIs in the left frontal cortex did not show significant regional changes in response to an earlier exposure to ketamine. These results suggest that ketamine treatment on PND 7 does not lead to metabolic alterations that are detectable at PND 35, even though it is known that such ketamine treatment causes severe neurotoxicity in this area (Zou et al., 2009) .
The second part of this study was designed to evaluate the neuronal damage on PND 35 that was induced by an earlier ketamine exposure. Apoptosis is defined as energy-dependent, genetically controlled cell death that may be activated by an internal suicide program (Lahorte et al., 2004; Zijlstra et al., 2003) . The most critical characteristics of cells entering apoptosis include cytoplasmic shrinkage, nuclear condensation, DNA degradation, cellular fragmentation, and changes in the plasma membrane structure. In contrast to normal cells, phosphatidylserine (PS), one of the four major phospholipids that make up the cell membrane, externalizes from the cytoplasmic to the extracellular side of the plasma membrane in cells in the apoptosis cascade (Allen et al., 1997; Fadok et al., 1992; Lahorte et al., 2004; Saraste and Pulkki 2000; Zijlstra et al., 2003) . The redistribution of PS to the exterior of the cell membrane in the early stages of apoptosis precedes most of the other hallmarks within the apoptosis process and serves as a signal to macrophages and adjacent normal cells to phagocytize and digest the components of the apoptotic cells (Schlegel and Williamson 2001; Strauss et al., 2008; Yagle et al., 2005) . Therefore, detection of externalized PS can be a very promising target for the early in vivo detection of programmed cell death.
Annexin V, a member of the superfamily of annexin proteins, is a 36-kDa endogenous human protein that selectively binds to PS. As an endogenous protein ligand, annexin V possesses high-affinity (Kd ¼ 7nM), Ca 2þ -dependent binding for PS. Therefore, annexin V has been selected for use as a radiotracer and labeled with various isotopes (Grierson et al., 2004; Lahorte et al., 2004; Strauss et al., 2008; Toretsky et al., 2004; Zijlstra et al., 2003) . Although annexin V is a relatively large protein, it has been demonstrated that the 99m Tc annexin V can be internalized at sites of ischemic injury in the brains of rabbits and humans and can cross the intact blood brain barrier (D'Arceuil et al., 2000; Lorberboym et al., 2006) . In practice, annexin V has been radiolabeled with different isotopes, such as 125 I, 124 I, 18 F, 99m T, and 68 G. In the present study, annexin V was radiolabeled with 18 F. According to the microPET image data for 18 F-annexin V, uptake of annexin V was evident in the brains of both control and ketamine-treated rats and the accumulation of the tracer peaked 5 min after injection. Compared with the control rats, in which the high radioactivity in the ROI decreased rapidly, the radioactivity in the ROI of ketamine-treated brains remained at a relatively high level for 40 min after the 18 F-annexin V injection. This result of a persisting signal in ketamine-treated brain is thought to represent the radiolabeled annexin V bound to the outer membranes of ketamine-induced apoptotic neurons, the sites expressing PS. However, necrotic neurons with ruptured plasma membranes can also enable the binding of the annexin V ligand since the intracellular PS molecules become easily accessible. While it is difficult to differentiate apoptotic from necrotic cells using PS targeting by 18 F-annexin V (Lahorte et al., 2004) , it seems clear that cellular degeneration caused by PND 7 exposure to ketamine persists for a much longer time than previously known.
Other observations of annexin V binding have demonstrated that PS can be expressed at low levels in neurons that are under pathophysiological stress (Lorberboym et al., 2006; Strauss et al., 2008) . For example, the surface exposure of PS can be induced by p53 activation, nitric oxide, and TNFa, and these early apoptotic cells with externalized PS can be rescued and even proliferate if the apoptotic stimulus is removed (Geske et al., 2001; Hammill et al., 1999; Martin et al., 2000; Yang et al., 2002) . Thus, PS exposure may allow the identification of tissues at risk for programmed cell death but that may be rescued by therapeutic intervention. microPET imaging with the radiotracer annexin V may be indicating brain regions of ketamine-induced injury that include stressed, apoptotic, and/or dying neurons.
Additionally, the expression pattern of Bax, a proapoptotic protein in the Bcl family, was evaluated using Western blot analysis. Consistent with the microPET imaging, the expression of Bax was increased in frontal cortical level of brain tissue, and quantitative densitometry revealed that the ratios of Bax to actin were significantly increased by ketamine, compared with controls, thus, suggesting the presence of ongoing apoptotic processes.
In summary, this is the first report on the application of microPET technology to quantify glucose metabolism and 18 F-annexin V labeling in the rat brain following early developmental exposure to ketamine. The imaging data demonstrate the ability and sensitivity of microPET in determining the principal sites of ketamine-induced neurodegeneration in the rat brain. Additionally, they demonstrate that microPET imaging with labeled annexin V is a minimally invasive approach for monitoring brain cell death. 
